Skip to main navigation Skip to search Skip to main content

Necrotizing Pancreatitis Related to Immune Checkpoint Inhibitor Therapy

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This is a case with Merkel cell carcinoma, received 6 doses of avelumab with subsequent severe necrotizing pancreatitis. The disease course after steroid treatment was complicated with pancreatic abscess/fistula and sepsis requiring prolonged antibiotics, frequent drain placement and long term TPN. Patient ultimately recovered from the event after 1 year. Over the follow up of 2 years, patient developed asymptomatic pancreatic atrophy, with cancer in remission despite ICI termination.

Original languageEnglish (US)
Title of host publicationChallenging Cases in Immunotherapy Related Organ Toxicities
PublisherSpringer Science+Business Media
Pages369-374
Number of pages6
ISBN (Electronic)9783031835339
ISBN (Print)9783031835322
DOIs
StatePublished - Jan 1 2025

Keywords

  • Adverse event
  • Contrast-enhanced computed tomography (CT) imaging
  • Immune checkpoint inhibitors
  • Pancreatitis
  • Toxicity

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Necrotizing Pancreatitis Related to Immune Checkpoint Inhibitor Therapy'. Together they form a unique fingerprint.

Cite this